🇺🇸 FDA
Patent

US 11780904

Method of producing recombinant high molecular weight vWF in cell culture

granted A61KA61K38/00A61K38/36

Quick answer

US patent 11780904 (Method of producing recombinant high molecular weight vWF in cell culture) held by Takeda Pharmaceutical Company Limited expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/36, A61K38/37, A61K9/0019